Latest News

Genetic evidence that new therapies targeting Parkinson's disease may cause harm

Researchers have completed a small study that shows genetic and clinical evidence that therapies targeting the expression of alpha-synuclein -- a gene whose function is involved in the development and progression of Parkinson?s disease -- may accelerate disease progression and increase the risk of physical incapacitation and dementia. If replicated, the findings will have profound implications for therapies under development for Parkinson?s disease.
View full story

Post your comment.


  • Loneliness triggers cellular changes that can cause illness, study shows

  • Adults born with heart defects have a substantially higher risk of stroke

  • Teaching problem-solving, leadership to young African-American girls lowers relational aggression

  • How cells in the developing ear 'practice' hearing

  • At the edge of vision: Struggling to make sense of our cluttered world

  • Contact with nature may mean more social cohesion, less crime

  • Willingness to adopt children with special needs the focus of recent study

  • Halteres, essential for flight in all flies, are needed by some to climb walls

  • Peering into cell structures where neurodiseases emerge

  • How cocaine changes the brain